Ajanta Pharma Ltd. (AJANTPHARM): Ajanta Pharma Share Price rises 2.04% to Rs 3,535 on market cap of Rs 43,291.43 crore
- September 7, 2026
- Posted by: Harsh Piplani
- Category: News
Ajanta Pharma Share Price was Rs 3,535, up 2.04% from the previous close, with market capitalisation at Rs 43,291.43 crore. The move keeps Ajanta Pharma Ltd. in focus in today’s stock news, even though the latest Univest data confirms the price event but does not establish a company-specific catalyst. For investors following Ajanta Pharma Share Price Today, the key question is not only what drove the rise, but how the stock’s valuation and business quality fit the broader Healthcare setup.
At 07 September 2026 at 12:22:58 PM IST, Ajanta Pharma Share Price had added Rs 70.55 from the previous close of Rs 3,464.45, while turnover stood at Rs 0.33 crore. The stock traded between Rs 3,433 and Rs 3,536.95 after opening at Rs 3,433. In other words, Ajanta Pharma Stock News today is less about a fresh narrative and more about a measured share price rise that places the name among Stocks Rising Today in the Indian Stock Market.
Ajanta Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,535 |
| Previous Close | Rs 3,464.45 |
| Today's Move | Rs 70.55 (+2.04%) |
| Open | Rs 3,433 |
| High | Rs 3,536.95 |
| Low | Rs 3,433 |
| Turnover | Rs 0.33 crore |
| Market Capitalisation | Rs 43,291.43 crore |
| Market Cap Category | Large Cap |
Ajanta Pharma Ltd. (AJANTPHARM) rose to Rs 3,535 from the previous close of Rs 3,464.45, a move of Rs 70.55 or 2.04%. The stock opened at Rs 3,433, reached a high of Rs 3,536.95, recorded a low of Rs 3,433.
Ajanta Pharma Share Price Today showed a steady intraday gain of 2.04%, with the stock last trading at Rs 3,535 after touching a high of Rs 3,536.95 and a low of Rs 3,433. The move is visible in price action, but the available market data confirms the rise rather than any specific trigger. For readers scanning Stocks in News, the share price rise reflects a positive opening tone and a position close to the day’s high. On Univest, this is the kind of move that typically draws attention to Ajanta Pharma Share Price Live and Ajanta Pharma Share Price Update pages, especially when the market is watching Market Movers in Healthcare.
Ajanta Pharma Ltd. (AJANTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 43,291.43 crore |
| P/E Ratio | 38.15x |
| P/B Ratio | 8.91x |
| ROE | 25.42% |
| ROCE | 32.67% |
| EPS | Rs 90.82 |
| Book Value Per Share | Rs 388.77 |
| Dividend Yield | 0.81% |
Ajanta Pharma Ltd. (AJANTPHARM) fundamental metrics show P/E 38.15x, P/B 8.91x, ROE 25.42%, ROCE 32.67%. These figures provide context only and are not a buy or sell signal.
Ajanta Pharma Ltd. has a market capitalisation of Rs 43291.43 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 38.15x, P/B at 8.91x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 25.42% and ROCE of 32.67%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 90.82, book value per share of Rs 388.77, dividend yield of 0.81%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 38.15x |
| Benchmark Median P/E | 32.83x |
| Benchmark Average P/E | 48.79x |
| Benchmark P/E Range | 3.2x to 659.73x |
| Company P/B Ratio | 8.91x |
| Benchmark Median P/B | 2.92x |
| Company ROE | 25.42% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 32.67% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 43,291.43 crore |
| Benchmark Median Market Cap | Rs 674.09 crore |
Ajanta Pharma Ltd. (AJANTPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 38.15x, which is above the benchmark median of 32.83x, a difference of +16.2%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ajanta Pharma Ltd. (AJANTPHARM) has a ROE of 25.42%, which is above the benchmark median of 11.78%, a difference of +115.79%. Ajanta Pharma Ltd. (AJANTPHARM) has a ROCE of 32.67%, which is above the benchmark median of 13.65%, a difference of +139.34%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,55,633.71 | 37.67 | 5.27 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,41,576.41 | 82.59 | 13.68 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,478.41 | 84.58 | 20.55 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,11,888.39 | 33.19 | 3.18 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,820.18 | 24.78 | 4.15 | 19.69 | 21.39 |
Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 38.15x compared with the displayed peer median of 37.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 25.42% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 32.67% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ajanta Pharma Ltd. (AJANTPHARM) has a market capitalisation of Rs 43,291.43 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Ajanta Pharma
- Ajanta Pharma Share Price rose 2.04% and traded near the day’s high, which keeps the stock on the radar of market participants.
- The company’s market cap of Rs 43,291.43 crore gives it meaningful weight within the Healthcare sector.
- ROE of 25.42% and ROCE of 32.67% add fundamental interest to the Ajanta Pharma Fundamental Analysis view.
- P/E of 38.15 and P/B of 8.91 keep valuation central to Ajanta Pharma Stock Analysis.
- Healthcare sector benchmarking shows the stock’s return ratios sit above the industry median, which supports continued market attention.
About Ajanta Pharma
Ajanta Pharma Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company is tracked on both NSE and BSE by investors looking at Ajanta Pharma Share Price, Ajanta Pharma Share Price Today and Ajanta Pharma Stock News. Its business profile is tied to pharmaceutical products and the broader drug market, which is why company-level price moves often get read alongside sector valuation and earnings quality.
Today’s Ajanta Pharma Share Price action matters because the stock combines a sizeable market cap with strong return ratios and a premium valuation. That makes the name relevant not only for short-term stock news followers but also for readers comparing Ajanta Pharma Share Price with other pharmaceutical counters. In a market where Healthcare names are often assessed through profit quality, pricing power and valuation discipline, Ajanta Pharma remains a closely watched Company News story.
Frequently Asked Questions
Why is Ajanta Pharma Share Price rising today?
Ans. Ajanta Pharma Share Price rose 2.04% to Rs 3,535, but the latest Univest data confirms the price event without identifying a company-specific catalyst. Investors are mainly tracking the move, market cap and valuation.
What is Ajanta Pharma Share Price Today?
Ans. Ajanta Pharma Share Price Today was Rs 3,535, up Rs 70.55 from the previous close of Rs 3,464.45. The stock also traded between Rs 3,433 and Rs 3,536.95 during the move.
What is Ajanta Pharma market capitalisation today?
Ans. Ajanta Pharma’s market capitalisation stands at Rs 43,291.43 crore. That places the company well above the industry median in the Pharmaceuticals & Drugs peer set and helps explain why the stock attracts attention.
How expensive is Ajanta Pharma on valuation?
Ans. Ajanta Pharma trades at a P/E of 38.15 and a P/B of 8.91. Compared with the industry median, both multiples are above average, so the stock looks premium versus many peers.
What do Ajanta Pharma ROE and ROCE indicate?
Ans. Ajanta Pharma reports ROE of 25.42% and ROCE of 32.67%. These are strong return ratios and indicate efficient use of shareholder equity and capital employed within the business.
How does Ajanta Pharma compare with sector peers?
Ans. Ajanta Pharma’s P/E is close to Sun Pharmaceutical Industries Ltd. and below Torrent Pharmaceuticals Ltd. and Divi’s Laboratories Ltd. Its ROE and ROCE compare favourably with several large peers in Healthcare.
What is Ajanta Pharma book value and EPS?
Ans. Ajanta Pharma has EPS of 90.82 and book value of Rs 388.77. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.
Should investors track Ajanta Pharma Stock News today?
Ans. Yes, because Ajanta Pharma Share Price, valuation ratios, market cap and Healthcare sector positioning all remain relevant today. Univest tracks Ajanta Pharma Share Price Live and related stock news for readers monitoring the name.
Track Ajanta Pharma Share Price on Univest
Use Ajanta Pharma Ltd. (AJANTPHARM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Ajanta Pharma Share Price Live on Univest for latest price updates, market cap, valuation ratios, sector context, company overview and stock insights. Univest also helps users follow Ajanta Pharma Share Price Today, Ajanta Pharma Share Price Update and Ajanta Pharma Latest News in one place.
For deeper stock research, Univest brings together company ratios, peer comparison, sector analysis, financial results and price update context. That makes it easier to review Ajanta Pharma Stock Performance without switching between multiple sources.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
